SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.260
+0.160 (5.16%)
Dec 20, 2024, 4:00 PM EST - Market closed
SOPHiA GENETICS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 64.49 | 62.37 | 47.56 | 40.45 | 28.4 | 25.36 |
| Revenue Growth (YoY) | 9.85% | 31.14% | 17.58% | 42.43% | 11.98% | - |
| Cost of Revenue | 20.75 | 19.46 | 16.31 | 15.23 | 10.71 | 7.53 |
| Gross Profit | 43.73 | 42.91 | 31.25 | 25.22 | 17.69 | 17.83 |
| Selling, General & Admin | 77.04 | 81.72 | 84.08 | 70.24 | 36.4 | 35.08 |
| Research & Development | 34.98 | 36.97 | 35.37 | 26.58 | 18.59 | 15.02 |
| Other Operating Expenses | -0.24 | -0.98 | -0.45 | -0.16 | -0.13 | 0.02 |
| Operating Expenses | 111.78 | 117.71 | 119 | 96.66 | 54.85 | 50.12 |
| Operating Income | -68.04 | -74.8 | -87.75 | -71.44 | -37.16 | -32.29 |
| Interest Expense | -0.59 | -0.59 | -0.64 | -0.66 | -0.84 | -0.98 |
| Interest & Investment Income | 2.87 | 4.55 | 1.32 | 0.02 | 0.1 | 0.09 |
| Currency Exchange Gain (Loss) | -5.26 | -7.63 | -0.45 | -1.38 | -2.71 | -0.35 |
| Other Non Operating Income (Expenses) | 0.27 | - | - | - | -0.38 | -0.1 |
| EBT Excluding Unusual Items | -70.75 | -78.47 | -87.51 | -73.46 | -41 | -33.63 |
| Gain (Loss) on Sale of Assets | -0.03 | -0.03 | - | -0.02 | - | - |
| Asset Writedown | - | - | -0.07 | -0.03 | -0.23 | - |
| Pretax Income | -70.78 | -78.5 | -87.59 | -73.51 | -41.23 | -33.63 |
| Income Tax Expense | 0.62 | 0.49 | -0.14 | 0.17 | -1.89 | 0.16 |
| Net Income | -71.4 | -78.98 | -87.45 | -73.68 | -39.34 | -33.79 |
| Net Income to Common | -71.4 | -78.98 | -87.45 | -73.68 | -39.34 | -33.79 |
| Shares Outstanding (Basic) | 66 | 65 | 64 | 55 | 42 | 38 |
| Shares Outstanding (Diluted) | 66 | 65 | 64 | 55 | 42 | 38 |
| Shares Change (YoY) | 1.84% | 1.02% | 15.91% | 30.58% | 12.11% | - |
| EPS (Basic) | -1.09 | -1.22 | -1.36 | -1.33 | -0.93 | -0.89 |
| EPS (Diluted) | -1.09 | -1.22 | -1.36 | -1.33 | -0.93 | -0.89 |
| Free Cash Flow | -43.83 | -50.07 | -74.19 | -60.62 | -32.18 | -33.04 |
| Free Cash Flow Per Share | -0.67 | -0.77 | -1.16 | -1.10 | -0.76 | -0.87 |
| Gross Margin | 67.82% | 68.80% | 65.71% | 62.35% | 62.29% | 70.30% |
| Operating Margin | -105.51% | -119.92% | -184.50% | -176.61% | -130.85% | -127.30% |
| Profit Margin | -110.71% | -126.63% | -183.87% | -182.14% | -138.52% | -133.23% |
| Free Cash Flow Margin | -67.96% | -80.28% | -155.99% | -149.87% | -113.31% | -130.25% |
| EBITDA | -67.21 | -72.94 | -86.46 | -67.83 | -35.4 | -30.74 |
| EBITDA Margin | -104.22% | -116.94% | -181.79% | -167.68% | -124.66% | -121.21% |
| D&A For EBITDA | 0.83 | 1.86 | 1.29 | 3.61 | 1.76 | 1.55 |
| EBIT | -68.04 | -74.8 | -87.75 | -71.44 | -37.16 | -32.29 |
| EBIT Margin | -105.51% | -119.92% | -184.50% | -176.61% | -130.85% | -127.30% |
Source: S&P Capital IQ. Standard template. Financial Sources.